Trial Profile
Clinical Trials Insight: 700037298
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2008
Price :
$35
*
At a glance
- Drugs YS 110 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions
- Sponsors Kissei Pharmaceutical
- 18 Sep 2008 New trial record.